NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 201290 | Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- | 0.0102077332082017 | 0.23981478 |
NSC 309401 | 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride | 0.0102077332082017 | 0.32284052 |
NSC 639976 | Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride | 0.0102077332082017 | 0.18727505 |
NSC 644916 | ANTINEOPLASTIC-644916 | 0.0102077332082017 | -0.0086588215 |
NSC 646498 | Null | 0.0102077332082017 | 0.25739405 |
NSC 44684 | Null | 0.011234153078014 | 0.27639631 |
NSC 669146 | 6,9-Epoxy-2H-1,4-dioxacyclodeca[cd]pentalene-2,7(4aH)-dione, 2a,3,5,6,11a,11b-hexahydro-3-hydroxy-2a,6,10-trimethyl-3-(1-methylethenyl)-, [2aS-(2aR*,3S*,4aR*,6S*,10Z,11aS*,11bS*)]- | 0.011234153078014 | 0.11185208 |
NSC 701666 | Benzenamine, N-[4-(4-chlorophenyl)-3-(2-propenyl)- 2(3H)-thiazolylidene]-2-methoxy-, hydrobromide, (2Z)- | 0.011234153078014 | -0.096330085 |
NSC 625731 | Null | 0.0112341530780143 | 0.2604078 |
NSC 113452 | Null | 0.0130238833303634 | 0.13976048 |